HUP0104800A3 - Chromenone and chromanone derivatives as integrin inhibitors, process for producing the same and pharmaceutical compositions containing them - Google Patents
Chromenone and chromanone derivatives as integrin inhibitors, process for producing the same and pharmaceutical compositions containing themInfo
- Publication number
- HUP0104800A3 HUP0104800A3 HU0104800A HUP0104800A HUP0104800A3 HU P0104800 A3 HUP0104800 A3 HU P0104800A3 HU 0104800 A HU0104800 A HU 0104800A HU P0104800 A HUP0104800 A HU P0104800A HU P0104800 A3 HUP0104800 A3 HU P0104800A3
- Authority
- HU
- Hungary
- Prior art keywords
- chromenone
- producing
- pharmaceutical compositions
- same
- compositions containing
- Prior art date
Links
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title 2
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical class C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000006495 integrins Human genes 0.000 title 1
- 108010044426 integrins Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19850131A DE19850131A1 (de) | 1998-10-30 | 1998-10-30 | Chromenon- und Chromanonderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104800A2 HUP0104800A2 (hu) | 2002-07-29 |
| HUP0104800A3 true HUP0104800A3 (en) | 2003-12-29 |
Family
ID=7886203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104800A HUP0104800A3 (en) | 1998-10-30 | 1999-10-14 | Chromenone and chromanone derivatives as integrin inhibitors, process for producing the same and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6849646B1 (hu) |
| EP (1) | EP1124824B1 (hu) |
| JP (1) | JP4511734B2 (hu) |
| KR (1) | KR20010080896A (hu) |
| CN (1) | CN1150189C (hu) |
| AR (1) | AR021029A1 (hu) |
| AT (1) | ATE370944T1 (hu) |
| AU (1) | AU754280B2 (hu) |
| BR (1) | BR9914893A (hu) |
| CA (1) | CA2348391C (hu) |
| CZ (1) | CZ20011515A3 (hu) |
| DE (2) | DE19850131A1 (hu) |
| ES (1) | ES2292252T3 (hu) |
| HU (1) | HUP0104800A3 (hu) |
| ID (1) | ID28482A (hu) |
| NO (1) | NO20012108L (hu) |
| PL (1) | PL347246A1 (hu) |
| RU (1) | RU2234505C2 (hu) |
| SK (1) | SK5532001A3 (hu) |
| WO (1) | WO2000026212A1 (hu) |
| ZA (1) | ZA200104411B (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19842415A1 (de) | 1998-09-16 | 2000-03-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
| US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| WO2002041910A2 (en) * | 2000-11-01 | 2002-05-30 | Merck Patent Gmbh | Methods and compositions for the treatment of diseases of the eye |
| MXPA03010893A (es) * | 2001-05-30 | 2004-10-28 | Univ Leland Stanford Junior | Sistema de suministro para acidos nucleicos. |
| MXPA04000839A (es) * | 2001-08-01 | 2004-05-14 | Merck Patent Gesellscahft Mit | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. |
| AU2003208833A1 (en) * | 2002-02-14 | 2003-09-04 | Merck Patent Gmbh | Methods and compositions for the treatment of eye diseases |
| DE60333094D1 (de) | 2002-04-17 | 2010-08-05 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
| US20060122387A1 (en) * | 2002-06-13 | 2006-06-08 | Cti Europe S.R.L. | Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
| FR2841243B1 (fr) * | 2002-06-19 | 2004-08-20 | Servier Lab | Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1539727B1 (en) | 2002-07-17 | 2009-02-18 | Cytokinetics, Inc. | Compounds, compositions, and methods for treating cellular proliferative diseases |
| DE10337863A1 (de) | 2003-08-18 | 2005-03-17 | Merck Patent Gmbh | Verwendung von Chromen-4-on-Derivaten |
| CN103450138B (zh) * | 2008-06-25 | 2015-04-08 | 阵列生物制药公司 | 制备6-取代的苯氧基色满羧酸衍生物的中间体 |
| WO2011156889A1 (en) * | 2010-06-14 | 2011-12-22 | Trt Pharma Inc. | Novel modulators of nrf2 and uses thereof |
| RU2612875C1 (ru) * | 2015-12-14 | 2017-03-13 | Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | Средство для ингибирования фермента тирозил-днк-фосфодиэстеразы 1 человека |
| CN112110902B (zh) * | 2020-09-17 | 2021-12-07 | 江苏科技大学 | 1-脱氧野尻霉素-山奈酚化合物、中间体，制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89840A (en) * | 1988-04-06 | 1996-10-31 | Lipha | Substituted flavonoid compounds and salts thereof their preparation and pharmaceutical composition containing them |
| US5703075A (en) * | 1988-12-21 | 1997-12-30 | Pharmacia & Upjohn Company | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| AU634994B2 (en) * | 1988-12-21 | 1993-03-11 | Pharmacia & Upjohn Company | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| EP0525123B1 (en) | 1990-06-20 | 1997-09-17 | PHARMACIA & UPJOHN COMPANY | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| FR2693196B1 (fr) * | 1992-07-03 | 1994-12-23 | Lipha | Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant. |
| US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| FR2717479B1 (fr) * | 1994-03-18 | 1996-06-07 | Pf Medicament | Nouvelles 3-(omega-benzoylpipéridino) alcoyl)-4H-Benzopyran-4-ones, leur préparation et leur application en thérapeutique. |
-
1998
- 1998-10-30 DE DE19850131A patent/DE19850131A1/de not_active Withdrawn
-
1999
- 1999-10-14 WO PCT/EP1999/007725 patent/WO2000026212A1/de active IP Right Grant
- 1999-10-14 PL PL99347246A patent/PL347246A1/xx unknown
- 1999-10-14 JP JP2000579600A patent/JP4511734B2/ja not_active Expired - Fee Related
- 1999-10-14 EP EP99952566A patent/EP1124824B1/de not_active Expired - Lifetime
- 1999-10-14 AU AU64716/99A patent/AU754280B2/en not_active Ceased
- 1999-10-14 CN CNB998142344A patent/CN1150189C/zh not_active Expired - Fee Related
- 1999-10-14 ID IDW00200101018A patent/ID28482A/id unknown
- 1999-10-14 HU HU0104800A patent/HUP0104800A3/hu unknown
- 1999-10-14 DE DE59914471T patent/DE59914471D1/de not_active Expired - Lifetime
- 1999-10-14 US US09/830,285 patent/US6849646B1/en not_active Expired - Fee Related
- 1999-10-14 AT AT99952566T patent/ATE370944T1/de not_active IP Right Cessation
- 1999-10-14 RU RU2001114188/04A patent/RU2234505C2/ru not_active IP Right Cessation
- 1999-10-14 KR KR1020017005079A patent/KR20010080896A/ko not_active Application Discontinuation
- 1999-10-14 SK SK553-2001A patent/SK5532001A3/sk unknown
- 1999-10-14 ES ES99952566T patent/ES2292252T3/es not_active Expired - Lifetime
- 1999-10-14 CA CA002348391A patent/CA2348391C/en not_active Expired - Fee Related
- 1999-10-14 BR BR9914893-5A patent/BR9914893A/pt not_active IP Right Cessation
- 1999-10-14 CZ CZ20011515A patent/CZ20011515A3/cs unknown
- 1999-10-29 AR ARP990105483A patent/AR021029A1/es not_active Application Discontinuation
-
2001
- 2001-04-27 NO NO20012108A patent/NO20012108L/no not_active Application Discontinuation
- 2001-05-29 ZA ZA200104411A patent/ZA200104411B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6849646B1 (en) | 2005-02-01 |
| HUP0104800A2 (hu) | 2002-07-29 |
| WO2000026212A1 (de) | 2000-05-11 |
| CN1150189C (zh) | 2004-05-19 |
| ES2292252T3 (es) | 2008-03-01 |
| CZ20011515A3 (cs) | 2001-08-15 |
| BR9914893A (pt) | 2001-07-17 |
| JP4511734B2 (ja) | 2010-07-28 |
| NO20012108D0 (no) | 2001-04-27 |
| AU754280B2 (en) | 2002-11-14 |
| EP1124824A1 (de) | 2001-08-22 |
| RU2234505C2 (ru) | 2004-08-20 |
| CA2348391A1 (en) | 2000-05-11 |
| CA2348391C (en) | 2009-09-29 |
| SK5532001A3 (en) | 2001-12-03 |
| PL347246A1 (en) | 2002-03-25 |
| ZA200104411B (en) | 2002-08-29 |
| CN1329610A (zh) | 2002-01-02 |
| EP1124824B1 (de) | 2007-08-22 |
| NO20012108L (no) | 2001-04-27 |
| ATE370944T1 (de) | 2007-09-15 |
| AU6471699A (en) | 2000-05-22 |
| KR20010080896A (ko) | 2001-08-25 |
| DE59914471D1 (de) | 2007-10-04 |
| AR021029A1 (es) | 2002-06-12 |
| ID28482A (id) | 2001-05-31 |
| JP2002528544A (ja) | 2002-09-03 |
| DE19850131A1 (de) | 2000-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9900120A3 (en) | Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0000748A2 (en) | 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0002893A3 (en) | Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0102084A3 (en) | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0103224A3 (en) | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0003311A3 (en) | Substituted 6-phenylphenanthridine derivatives, pocess for producing them and pharmaceutical compositions containing them | |
| HUP0102466A3 (en) | Antiestrogenic novel benzopyran or thiobenzopyran derivatives, process for producing them and medicaments containing them | |
| HUP0303109A3 (en) | Indolin-2-one derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0303118A3 (en) | Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them | |
| HUP0104800A3 (en) | Chromenone and chromanone derivatives as integrin inhibitors, process for producing the same and pharmaceutical compositions containing them | |
| HUP0102622A3 (en) | Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9801423A3 (en) | Chromene derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9802121A3 (en) | Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HK1036985A1 (en) | Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0105479A3 (en) | Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0103316A3 (en) | 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use | |
| HUP0204001A3 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303361A3 (en) | Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0104819A3 (en) | Chroman derivatives, their use intermediate and process for their preparation | |
| HUP0100432A3 (en) | Pyridyle derivatives as antivirals, process for producing them and pharmaceutical compositions containing them | |
| HUP0201916A2 (en) | Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0003766A3 (en) | Isoguinolin derivatives, process for producing them and pharmaceutical compositions containing them | |
| HK1038927A1 (en) | (1-Phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same | |
| HUP0201404A2 (en) | Aminoalkyl substituted benzodioxan, benzofuran or benzopyran derivatives, pharmaceutical compositions containing them and their use and process for their preparations | |
| HUP0003997A3 (en) | 3-benzylpiperidine derivatives, pharmaceutical compositions containing them and process for producing them |